Stock vs Stock Comparison

AtaiBeckley Inc. vs AbbVie Inc.

ABBV wins the Tale of the Tape 7–2.

ATAI$4.81
ABBV$215.40

🏆 Tale of the Tape

27
ATAIABBV
-16142.0%Profitability (Net Margin)6.9%
Valuation (P/E)106.2x
-193.3%Efficiency (ROIC)8.3%
3/9Health (Piotroski F)7/9
-1.6Safety (Altman Z)2.0
1227.6%Growth (Rev YoY)8.6%
1.66Risk (Sharpe 1Y)0.61
0.32xBalance Sheet (D/E)-42.50x
-9.14%FCF Yield4.23%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.140
252-Day Correlation
0.108
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricATAIABBV
Market Cap$1.7B$384.7B
P/E Ratio106.2x
Forward P/E-10.0x13.4x
P/B8.15x-57.80x
Dividend Yield3.18%
Beta1.600.30

Quantitative Metrics

MetricATAIABBV
DCF Fair Value$126.26
DCF Upside-38.9%
Piotroski F3/97/9
Altman Z-1.622.01
Beneish M-2.87
FCF Yield-9.14%4.23%
Net Debt/EBITDA3.0x
ROIC-193.3%8.3%
WACC7.4%
ROIC – WACC0.8pp
Gross Margin70.2%
Net Margin-16142.0%6.9%
Rev Growth YoY1227.6%8.6%
Sharpe (1Y)1.660.61
Max Drawdown 3Y-59.2%
FCF Payout Ratio65%

ATAI Price

Loading chart...

ABBV Price

Loading chart...

ETF Exposure

ABBV found in:

XLV7.07%
IYH6.86%
VHT6.04%
HDV5.61%
SCHD3.53%
DGRO2.52%
DGRW1.99%
MGV1.85%
VIG1.68%
VYM1.56%
NOBL1.49%
VTV1.46%
SDY1.42%
IWF1.39%
SCHV1.38%
VONG1.21%
XBI1.09%
ESGV0.78%
SPYV0.71%
IVV0.69%
SPLG0.68%
SCHX0.66%
SCHB0.62%
ITOT0.61%
VOO0.60%
SPY0.59%
VONE0.57%
SPTM0.55%
VTI0.54%
SPYG0.50%
URTH0.48%
ACWI0.41%
VFVA0.41%
VT0.33%
QUS0.32%
VFMV0.25%
RSP0.19%
ONEO0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ATAI vs ABBV: Head-to-Head Analysis

AtaiBeckley Inc. (ATAI) and AbbVie Inc. (ABBV) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABBV leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ATAI generates a return on invested capital (ROIC) of -193.3% compared to ABBV's 8.3%. This suggests ABBV is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ATAI and ABBV is 0.140, indicating low correlation, making them an effective diversification pair in a portfolio context.

ABBV appears in 38 ETFs.

Frequently Asked Questions

Which stock is the better investment, ATAI or ABBV?

Our quantitative analysis compares ATAI and ABBV across nine fundamental dimensions. ABBV wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ATAI and ABBV correlated?

The 252-day correlation between ATAI and ABBV is 0.140. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.